Bioinformatic Analysis Of Important Mirna And Gene-Network Analysis Of Smarcb1 Gene, A Key Regulator Of Head And Neck Cancer
DOI:
https://doi.org/10.53555/jaz.v43iS2.5357Keywords:
SMARCB1, microRNA, hsa-miR-4283, head and neck cancer, bioinformatics, gene network analysis, tumor suppressor, chromatin remodelingAbstract
Background: MicroRNAs (miRNAs) are small non-coding RNAs that play critical roles in gene regulation by suppressing translation or promoting mRNA decay of target transcripts. SMARCB1, a core subunit of the SWI/SNF chromatin remodeling complex located on chromosome 22q11.2, functions as a tumor suppressor and is frequently inactivated in malignant rhabdoid tumors, schwannomatosis, and other malignancies. Despite the established importance of SMARCB1 in cancer biology, the miRNA-mediated regulation of this gene remains poorly characterized, particularly in the context of head and neck cancer.
Objective: This study aimed to identify and characterize miRNAs targeting the SMARCB1 gene using computational bioinformatics approaches and to analyze the protein-protein interaction network of SMARCB1 to better understand its functional context in cancer biology.
Methods: MiRNA target prediction for the SMARCB1 gene was performed using the miRDB online database. Predicted interactions were filtered based on target scores, with a threshold of >90 applied for high-confidence predictions. Gene network analysis of SMARCB1 and BRAF was carried out using the STRING database online server program, with important gene interactions requiring a combined confidence score of >0.99 for inclusion. Target prediction for conserved miRNA families was also performed using the GDC data portal.
Results: A total of 49 miRNAs were predicted to target the SMARCB1 gene through miRDB analysis. Among these, one miRNA, hsa-miR-4283, demonstrated a high-confidence target score exceeding 90 and was selected for further investigation. Gene network analysis revealed significant interactions between SMARCB1 and several genes including NEK7, PLS3, KIAA0408, PTAR1, and NR1D2, with combined confidence scores >0.99. These interactions place SMARCB1 within a broader network involving cell cycle regulation, cytoskeletal organization, and transcriptional control. Parallel analysis of BRAF interactions provided comparative data on miRNA involvement in cancer-associated signaling pathways.
Conclusion: This study identifies hsa-miR-4283 as a high-confidence candidate regulator of SMARCB1 expression and reveals the protein interaction network context in which this tumor suppressor operates. The findings provide a foundation for experimental validation studies and suggest that miRNA-mediated regulation of SMARCB1 could contribute to cancer pathogenesis in head and neck malignancies and other tumor types where SMARCB1 plays a critical role. Further investigation of hsa-miR-4283 expression in tumor tissues and its functional effects on SMARCB1 expression is warranted.
Downloads
References
1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215-233. doi:10.1016/j.cell.2009.01.002
2. Bracken CP, Scott HS, Goodall GJ. A network-biology perspective of microRNA function and dysfunction in cancer. Nat Rev Genet. 2016;17(12):719-732. doi:10.1038/nrg.2016.134
3. Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet. 2007;80(4):805-810. doi:10.1086/513207
4. Bacci C, Sestini R, Provenzano A, et al. Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation. Neurogenetics. 2010;11(1):73-80. doi:10.1007/s10048-009-0221-1
5. van den Munckhof P, Christiaans I, Kenter SB, Baas F, Hulsebos TJ. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri. Neurogenetics. 2012;13(1):1-7. doi:10.1007/s10048-011-0300-y
6. Roberts CWM, Biegel JA. The role of SMARCB1/INI1 in development of rhabdoid tumor. Cancer Biol Ther. 2009;8(5):412-416. doi:10.4161/cbt.8.5.8019
7. Chun HE, Lim EL, Heravi-Moussavi A, et al. Genome-wide profiles of extra-cranial malignant rhabdoid tumors reveal heterogeneity and dysregulated developmental pathways. Cancer Cell. 2016;29(3):394-406. doi:10.1016/j.ccell.2016.02.009
8. Kim KH, Roberts CW. Targeting EZH2 in cancer. Nat Med. 2016;22(2):128-134. doi:10.1038/nm.4044
9. Angius A, Pira G, Scanu AM, et al. MicroRNA-425-5p expression affects BRAF/RAS/MAPK pathways in colorectal cancers. Int J Med Sci. 2019;16(11):1480-1491. doi:10.7150/ijms.35269
10. De Cecco L, Giannoccaro M, Marchesi E, et al. Integrative miRNA-gene expression analysis enables refinement of associated biology and prediction of response to cetuximab in head and neck squamous cell cancer. Genes Chromosomes Cancer. 2017;56(7):525-537. doi:10.1002/gcc.22457
11. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15-20. doi:10.1016/j.cell.2004.12.035
12. Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127-D131. doi:10.1093/nar/gkz757
13. Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607-D613. doi:10.1093/nar/gky1131
14. Grossman RL, Heath AP, Ferretti V, et al. Toward a shared vision for cancer genomic data. N Engl J Med. 2016;375(12):1109-1112. doi:10.1056/NEJMp1607591
15. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857-866. doi:10.1038/nrc1997
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Preethi Raj, Dr. Smiline
This work is licensed under a Creative Commons Attribution 4.0 International License.
